Selmer, Johan, Birgitte Vestbjerg, Morten Præstegaard, and Linda Stein Gold. “Phase 3 Trial Demonstrates That MC2-01 Cream Has Improved Treatment Efficacy Compared to Calcipotriene Plus Betamethasone Dipropionate Topical Suspension in Patients With Mild to Moderate Psoriasis Vulgaris”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s36. Accessed October 29, 2020. https://jofskin.org/index.php/skin/article/view/985.